FDA Commissioner Marty Makary Resigns Amid Industry and White House Backlash

Marty Makary has stepped down as commissioner of the US Food and Drug Administration, CNBC reported. His resignation follows months of sustained criticism from pharmaceutical companies and physicians, alongside mounting frustration inside the White House. The agency's recent regulatory decisions strained relations with the sector.

Appointed last year by President Donald Trump, Makary brought a more flexible posture to public-health policy, according to the report. His tenure was marked by internal leadership turmoil and delays on senior appointments. CNBC said the consecutive departures of top deputies disrupted the agency's day-to-day operations.

The Trump administration is expected to name a replacement in the coming weeks. Drugmakers are hoping for a more predictable approval pipeline under new leadership. Officials have not publicly identified potential candidates.